跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Inoflox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Inoflox
Approved
STANDARD
Inoflox
Santen Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b5f01fbe1044f8ad
Company
Santen Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
b5f01fbe1044f8ad
Drug Approval Philippines Name
Inoflox
Product Name
Inoflox
Registration Number
DR-XY21447
Brand Name
Inoflox
Generic Name
Ofloxacin
Dosage Form
Otic Solution
Dosage Strength
3 mg/mL
Manufacturer
Santen Pharmaceutical Co., Ltd.
Distributor
United Laboratories, Inc.
Company Detail Path
/organization/santen-pharmaceutical-co-ltd
Issuance Date
28 April 2022
Expiry Date
07 June 2027
Pharmacologic Category
Antibacterial (Quinolone)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b5f01fbe1044f8ad
Type
Standard
Back to Philippines FDA Approvals